null

H8 Biosimilar (Anti-5T4) Antibody (HDBS0137)

SKU:
HDBS0137
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
5T4
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399

Description

system_update_altDatasheet

H8 (Anti-5T4) Biosimilar Antibody (HDBS0137)

The H8 Biosimilar Anti-5T4 Antibody is a recombinant monoclonal antibody designed for research involving 5T4, a cell surface antigen associated with tumor growth and metastasis. The antibody, developed using cutting-edge biosimilar technology, is highly specific and exhibits potent anti-tumor activity in preclinical studies.5T4 is a promising target for cancer therapy due to its overexpression in a wide range of solid tumors, making it a potential biomarker for diagnosis and targeted treatment.

The H8 Antibody binds specifically to the 5T4 antigen, blocking its function and inhibiting tumor cell proliferation and migration.This biosimilar antibody offers a novel approach to cancer therapy, with the potential to improve treatment outcomes and reduce side effects compared to traditional chemotherapy. Its unique mechanism of action and high specificity make it a valuable tool for studying tumor biology and developing personalized treatment strategies for cancer patients.